GlyCosmos PubAnnotations

Recent publication annotations of glycans, cell types, and proteins, from PubAnnotation.

Displaying entries 15251 - 15275 of 24862 in total
Title ▼ Authors PubMed ID Source Publication Year
Heparin regulates vascular endothelial growth factor165-dependent mitogenic activity, tube formation, and its receptor phosphorylation of human endothelial cells. Comparison of the effects of heparin and modified heparins.
  • Ashikari-Hada S
  • Habuchi H
  • Kariya Y
  • Kimata K
16027124 J Biol Chem 2005
Heparin protects cathepsin G against inhibition by protein proteinase inhibitors.
  • Ermolieff J
  • Boudier C
  • Laine A
  • Meyer B
  • Bieth JG
7961933 J Biol Chem 1994
Heparin promotes the binding of thrombin to fibrin polymer. Quantitative characterization of a thrombin-fibrin polymer-heparin ternary complex.
  • Hogg PJ
  • Jackson CM
2294104 J Biol Chem 1990
Heparin promotes proteolytic inactivation by thrombin of a reactive site mutant (L444R) of recombinant heparin cofactor II.
  • Ciaccia AV
  • Willemze AJ
  • Church FC
8995378 J Biol Chem 1997
Heparin promotes fibrillation of most phenol-soluble modulin virulence peptides from Staphylococcus aureus.
  • Najarzadeh Z
  • Zaman M
  • Sereikaite V
  • Strømgaard K
  • Andreasen M
  • Otzen DE
34270957 J Biol Chem 2021
Heparin prevents vascular smooth muscle cell progression through the G1 phase of the cell cycle.
  • Reilly CF
  • Kindy MS
  • Brown KE
  • Rosenberg RD
  • Sonenshein GE
2651437 J Biol Chem 1989
Heparin prevents intracellular hyaluronan synthesis and autophagy responses in hyperglycemic dividing mesangial cells and activates synthesis of an extensive extracellular monocyte-adhesive hyaluronan matrix after completing cell division.
  • Wang A
  • Ren J
  • Wang CP
  • Hascall VC
24482224 J Biol Chem 2014
Heparin potentiates the in vivo ectopic bone formation induced by bone morphogenetic protein-2.
  • Zhao B
  • Katagiri T
  • Toyoda H
  • Takada T
  • Yanai T
  • Fukuda T
  • Chung UI
  • Koike T
  • Takaoka K
  • Kamijo R
16754660 J Biol Chem 2006
Heparin potentiates in vivo neutrophil migration induced by IL-8.
  • Dias-Baruffi M
  • Pereira-da-Silva G
  • Jamur MC
  • Roque-Barreira MC
9881755 Glycoconj J 1998
Heparin potentiates Avastin-mediated inhibition of VEGF binding to fibronectin and rescues Avastin activity at acidic pH.
  • Tsiros D
  • Sheehy CE
  • Pecchia S
  • Nugent MA
31601651 J Biol Chem 2019
Heparin oligosaccharides inhibit chemokine (CXC motif) ligand 12 (CXCL12) cardioprotection by binding orthogonal to the dimerization interface, promoting oligomerization, and competing with the chemokine (CXC motif) receptor 4 (CXCR4) N terminus.
  • Ziarek JJ
  • Veldkamp CT
  • Zhang F
  • Murray NJ
  • Kartz GA
  • Liang X
  • Su J
  • Baker JE
  • Linhardt RJ
  • Volkman BF
23148226 J Biol Chem 2013
Heparin oligosaccharide sequence and size essential for inhibition of pulmonary artery smooth muscle cell proliferation.
  • Garg HG
  • Cindhuchao N
  • Quinn DA
  • Hales CA
  • Thanawiroon C
  • Capila I
  • Linhardt RJ
12433502 Carbohydr Res 2002
Heparin nanoparticles for β amyloid binding and mitigation of β amyloid associated cytotoxicity.
  • Wang P
  • Kouyoumdjian H
  • Zhu DC
  • Huang X
25498198 Carbohydr Res 2015
Heparin modulation of laminin polymerization.
  • Yurchenco PD
  • Cheng YS
  • Schittny JC
2303489 J Biol Chem 1990
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors.
  • Tessler S
  • Rockwell P
  • Hicklin D
  • Cohen T
  • Levi BZ
  • Witte L
  • Lemischka IR
  • Neufeld G
8175651 J Biol Chem 1994
Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells.
  • Andress DL
7499327 J Biol Chem 1995
Heparin modulates the 99-loop of factor IXa: effects on reactivity with isolated Kunitz-type inhibitor domains.
  • Neuenschwander PF
  • Williamson SR
  • Nalian A
  • Baker-Deadmond KJ
16766524 J Biol Chem 2006
Heparin is a unique marker of progenitors in the glial cell lineage.
  • Stringer SE
  • Mayer-Proschel M
  • Kalyani A
  • Rao M
  • Gallagher JT
10464276 J Biol Chem 1999
Heparin is a major activator of the anticoagulant serpin, protein Z-dependent protease inhibitor.
  • Huang X
  • Rezaie AR
  • Broze GJ Jr
  • Olson ST
21220417 J Biol Chem 2011
Heparin inhibits the reconstituted plasma membrane Ca(2+)-ATPase from porcine brain synaptosome.
  • Zhao Y
  • Zhang X
14707483 Glycoconj J 2002
Heparin inhibits the binding of beta 2-glycoprotein I to phospholipids and promotes the plasmin-mediated inactivation of this blood protein. Elucidation of the consequences of the two biological events in patients with the anti-phospholipid syndrome.
  • Guerin J
  • Sheng Y
  • Reddel S
  • Iverson GM
  • Chapman MG
  • Krilis SA
11711550 J Biol Chem 2002
Heparin inhibits proinflammatory and promotes anti-inflammatory macrophage polarization under hyperglycemic stress.
  • Abbadi A
  • Loftis J
  • Wang A
  • Yu M
  • Wang Y
  • Shakya S
  • Li X
  • Maytin E
  • Hascall V
32107314 J Biol Chem 2020
Heparin inhibits mitogen-activated protein kinase-dependent and -independent c-fos induction in mesangial cells.
  • Miralem T
  • Wang A
  • Whiteside CI
  • Templeton DM
8663360 J Biol Chem 1996
Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells.
  • Ottlinger ME
  • Pukac LA
  • Karnovsky MJ
7690027 J Biol Chem 1993
Heparin influence on the complex of serum amyloid P component and complement C4b-binding protein.
  • Schwalbe RA
  • Dahlbäck B
  • Nelsestuen GL
2071579 J Biol Chem 1991

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024